Stock Price
68.05
Daily Change
0.70 1.04%
Monthly
-7.60%
Yearly
18.97%
Q2 Forecast
66.42

Orion reported EUR91.9M in Selling and Administration Expenses for its fiscal quarter ending in March of 2026.





Selling And Administration Expenses Change Date
Hikma Pharmaceutical USD 288M 149M Dec/2025
Oriola-kd EUR 13M 3.1M Sep/2025
Recordati EUR 187.24M 15.86M Dec/2025
UCB EUR 1.47B 193M Dec/2025